This recorded lecture was part of our 2025 Free Webinar Series and sponsored by Agepha Pharma and Rated Doctor, presented by Dr. Yasmine Abdalla. Age-related macular degeneration (AMD) advances through early, intermediate, and late stages. While anti-VEGF therapies are effective for wet AMD, there are no approved treatments currently available for dry AMD in the UK. Emerging approaches, including sustained-release anti-VEGF, gene therapy, and complement inhibitors, offer hope for dry AMD. This recorded lecture explores cutting-edge advancements and strategies to preserve vision.